Annual Retained Earnings
-$764.41 M
-$338.79 M-79.60%
31 December 2023
Summary:
Spyre Therapeutics annual retained earnings is currently -$764.41 million, with the most recent change of -$338.79 million (-79.60%) on 31 December 2023. During the last 3 years, it has fallen by -$422.61 million (-123.64%). SYRE annual retained earnings is now -39363.81% below its all-time high of -$1.94 million, reached on 01 December 2013.SYRE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$916.14 M
-$69.03 M-8.15%
30 September 2024
Summary:
Spyre Therapeutics quarterly retained earnings is currently -$916.14 million, with the most recent change of -$69.03 million (-8.15%) on 30 September 2024. Over the past year, it has dropped by -$151.72 million (-19.85%). SYRE quarterly retained earnings is now -7357.96% below its all-time high of -$12.28 million, reached on 01 December 2014.SYRE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -19.9% |
| 3 y3 years | -123.6% | -168.0% |
| 5 y5 years | -291.8% | -369.5% |
SYRE Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -123.6% | at low | -168.0% | at low |
| 5 y | 5 years | -291.8% | at low | -369.5% | at low |
| alltime | all time | <-9999.0% | at low | -7358.0% | at low |
Spyre Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$916.14 M(+8.1%) |
| June 2024 | - | -$847.11 M(+4.8%) |
| Mar 2024 | - | -$808.27 M(+5.7%) |
| Dec 2023 | -$764.41 M(+79.6%) | -$764.41 M(+9.0%) |
| Sept 2023 | - | -$701.23 M(+6.1%) |
| June 2023 | - | -$661.13 M(+48.9%) |
| Mar 2023 | - | -$444.05 M(+4.3%) |
| Dec 2022 | -$425.62 M(+24.5%) | - |
| Dec 2022 | - | -$425.62 M(+4.6%) |
| Sept 2022 | - | -$406.80 M(+4.7%) |
| June 2022 | - | -$388.57 M(+6.1%) |
| Mar 2022 | - | -$366.25 M(+7.1%) |
| Dec 2021 | -$341.81 M(+23.8%) | -$341.81 M(+6.4%) |
| Sept 2021 | - | -$321.36 M(+6.7%) |
| June 2021 | - | -$301.06 M(+2.3%) |
| Mar 2021 | - | -$294.23 M(+6.6%) |
| Dec 2020 | -$276.01 M(+41.5%) | -$276.01 M(+9.0%) |
| Sept 2020 | - | -$253.29 M(+7.7%) |
| June 2020 | - | -$235.26 M(+10.0%) |
| Mar 2020 | - | -$213.84 M(+9.6%) |
| Dec 2019 | -$195.12 M | -$195.12 M(+12.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -$173.62 M(+14.2%) |
| June 2019 | - | -$152.05 M(+13.4%) |
| Mar 2019 | - | -$134.03 M(+14.7%) |
| Dec 2018 | -$116.86 M(+61.2%) | -$116.86 M(+14.6%) |
| Sept 2018 | - | -$101.96 M(+13.2%) |
| June 2018 | - | -$90.05 M(+11.7%) |
| Mar 2018 | - | -$80.63 M(+11.2%) |
| Dec 2017 | -$72.51 M(+60.2%) | -$72.51 M(+9.8%) |
| Sept 2017 | - | -$66.03 M(+13.5%) |
| June 2017 | - | -$58.16 M(+12.9%) |
| Mar 2017 | - | -$51.52 M(+13.8%) |
| Dec 2016 | -$45.28 M(+92.0%) | -$45.28 M(+13.8%) |
| Sept 2016 | - | -$39.79 M(+18.6%) |
| June 2016 | - | -$33.56 M(+19.3%) |
| Mar 2016 | - | -$28.13 M(+19.3%) |
| Dec 2015 | -$23.58 M(+91.9%) | -$23.58 M(+20.4%) |
| Sept 2015 | - | -$19.59 M(+21.1%) |
| June 2015 | - | -$16.18 M(+9.7%) |
| Mar 2015 | - | -$14.75 M(+20.1%) |
| Dec 2014 | -$12.28 M(+534.2%) | -$12.28 M |
| Dec 2013 | -$1.94 M | - |
FAQ
- What is Spyre Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly retained earnings year-on-year change?
What is Spyre Therapeutics annual retained earnings?
The current annual retained earnings of SYRE is -$764.41 M
What is the all time high annual retained earnings for Spyre Therapeutics?
Spyre Therapeutics all-time high annual retained earnings is -$1.94 M
What is Spyre Therapeutics quarterly retained earnings?
The current quarterly retained earnings of SYRE is -$916.14 M
What is the all time high quarterly retained earnings for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly retained earnings is -$12.28 M
What is Spyre Therapeutics quarterly retained earnings year-on-year change?
Over the past year, SYRE quarterly retained earnings has changed by -$151.72 M (-19.85%)